Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 May;45(1):48–59. doi: 10.1111/j.1476-5381.1972.tb09575.x

The physiological disposition of 14C-methsuximide in the rat

P J Nicholls, T C Orton
PMCID: PMC1666192  PMID: 5041507

Abstract

1. 14C-Methsuximide (N-methyl-14C-2-methyl-2-phenylsuccinimide) was rapidly absorbed from the small intestine of the rat (t½ 17·4 min).

2. The drug was rapidly and fairly evenly distributed throughout the body with peak blood and tissue levels occurring 1 h after oral administration. At all times, adrenals, body fat, kidneys and liver had higher levels of 14C-methsuximide than other tissues and the drug freely traversed the blood-brain barrier. However, radioactivity disappeared rapidly from most tissues after the initial phase of the distribution.

3. During 24 h, 26% of the orally administered radioactivity was recovered in urine and 29% appeared in expired air as 14CO2. The excretion of 14CO2 indicated N-demethylation of 14C-methsuximide to 2-methyl-2-phenylsuccinimide. 2·7% of an administered dose of methsuximide was excreted unchanged in 24 h urine and 2·7% appeared as 2-methyl-2-phenylsuccinimide. 2-Methyl-2-phenylsuccinimide was also detected as a urinary metabolite of methsuximide in man.

4. 2-Methyl-2-phenylsuccinimide possesses anticonvulsant activity and it is suggested that this metabolite contributes to the overall anticonvulsant activity and toxicity of methsuximide.

5. Rat urine also contained a radioactive substance with similar chromatographic properties to one of the products of alkaline hydrolysis of methsuximide. This compound may arise from the spontaneous decomposition of the parent drug in vivo.

Full text

PDF
48

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akagi M., Aoki I., Uematsu T. Studies on food additives. X. The metabolism of p-ethoxyphenylurea in the rabbit. Chem Pharm Bull (Tokyo) 1966 Jan;14(1):1–9. doi: 10.1248/cpb.14.1. [DOI] [PubMed] [Google Scholar]
  2. BUTLER T. C. Quantitative studies of the demethylation of trimethadione (tridione). J Pharmacol Exp Ther. 1953 May;108(1):11–17. [PubMed] [Google Scholar]
  3. BUTLER T. C., WADDELL W. J. N-methylated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy. Neurology. 1958 Apr;8(Suppl 1):106–112. doi: 10.1212/wnl.8.suppl_1.106. [DOI] [PubMed] [Google Scholar]
  4. BUTLER T. C., WADDELL W. J. The role of the liver in the demethylation of N-methyl derivatives of hydantoin and of 2,4-oxazolidinedione. J Pharmacol Exp Ther. 1954 Feb;110(2):241–243. [PubMed] [Google Scholar]
  5. Birchfield R. I., Cowger M. L. Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes. Am J Dis Child. 1966 Dec;112(6):561–565. doi: 10.1001/archpedi.1966.02090150105011. [DOI] [PubMed] [Google Scholar]
  6. Butler T. C., Waddell W. J., Poole D. T. Demethylation of trimethadione and metharbital by rat liver microsomal enzymes: substrate concentration--yield relationships and competition between substrates. Biochem Pharmacol. 1965 Jun;14(6):937–942. doi: 10.1016/0006-2952(65)90245-5. [DOI] [PubMed] [Google Scholar]
  7. CARTER C. H., MALEY M. C. Use of celontin in the treatment of mixed epilepsy. Neurology. 1957 Jul;7(7):483–484. doi: 10.1212/wnl.7.7.483. [DOI] [PubMed] [Google Scholar]
  8. CHAMBERLIN H. R., WADDELL W. J., BUTLER T. C. A STUDY OF THE PRODUCT OF DEMETHYLATION OF TRIMETHADIONE IN THE CONTROL OF PETIT MAL EPILEPSY. Neurology. 1965 May;15:449–454. doi: 10.1212/wnl.15.5.449. [DOI] [PubMed] [Google Scholar]
  9. CHEN G., PORTMAN R., ENSOR C. R., BRATTON A. C., Jr The anticonvulsant activity of o-phenyl succinimides. J Pharmacol Exp Ther. 1951 Sep;103(1):54–61. [PubMed] [Google Scholar]
  10. CHEN G., WESTON J. K., BRATTON A. C., Jr Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide. Epilepsia. 1963 Mar;4:66–76. doi: 10.1111/j.1528-1157.1963.tb05209.x. [DOI] [PubMed] [Google Scholar]
  11. DOW R. S., MACFARLANE J. P., STEVENS J. R. Celontin in patients with refractory epilepsy. Neurology. 1958 Mar;8(3):201–204. doi: 10.1212/wnl.8.3.201. [DOI] [PubMed] [Google Scholar]
  12. Doluisio J. T., Billups N. F., Dittert L. W., Sugita E. T., Swintosky J. V. Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. J Pharm Sci. 1969 Oct;58(10):1196–1200. doi: 10.1002/jps.2600581006. [DOI] [PubMed] [Google Scholar]
  13. FINGL E., McQUARRIE D. G. Evaluation of variables for the 'timed intravenous infusion' procedure for pentyleneterazol seizures in mice. Arch Int Pharmacodyn Ther. 1960 Jun 1;126:17–30. [PubMed] [Google Scholar]
  14. Hall T. C., Cocking E. C. High-efficiency liquid-scintillation counting of 14C-labelled material in aqueous solution and determination of specific activity of labelled proteins. Biochem J. 1965 Sep;96(3):626–633. doi: 10.1042/bj0960626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Huisman J. W. The estimation of some important anticonvulsant drugs in serum. Clin Chim Acta. 1966 Mar;13(3):323–328. doi: 10.1016/0009-8981(66)90211-7. [DOI] [PubMed] [Google Scholar]
  16. JENSEN B. N. Trimethadione in serum of patients with petit mal epilepsy. Dan Med Bull. 1962 Jun;9:74–79. [PubMed] [Google Scholar]
  17. Nicholls P. J., Orton T. C. Absorption, distribution and excretion of methsuximide in male rats. Br J Pharmacol. 1971 Oct;43(2):459P–460P. [PMC free article] [PubMed] [Google Scholar]
  18. Petroff C. P., Patt H. H., Nair P. P. A rapid method for dissolving tissue for liquid scintillation counting. Int J Appl Radiat Isot. 1965 Oct;16(10):599–601. doi: 10.1016/0020-708x(65)90096-7. [DOI] [PubMed] [Google Scholar]
  19. WADDELL W. J., BUTLER T. C. Renal excretion of 5,5-dimethyl-2-4-oxazolidinedione (product of demethylation of trimethadione. Proc Soc Exp Biol Med. 1957 Dec;96(3):563–565. doi: 10.3181/00379727-96-23540. [DOI] [PubMed] [Google Scholar]
  20. Yeh S. Y., Woods L. A. Physiologic disposition of N-C14-methyl-codeine in the rat. J Pharmacol Exp Ther. 1969 Mar;166(1):86–95. [PubMed] [Google Scholar]
  21. ZIMMERMAN F. T. Evaluation of N-methyl-a, a-methylphenyl succinimide in the treatment of petit mal epilepsy. N Y State J Med. 1956 May 1;56(9):1460–1465. [PubMed] [Google Scholar]
  22. ZIMMERMAN F. T. New drugs in the treatment of petit mal epilepsy. Am J Psychiatry. 1953 Apr;109(10):767–773. doi: 10.1176/ajp.109.10.767. [DOI] [PubMed] [Google Scholar]
  23. el-Zanfally S., Khalifa M., Abou-Zeid Y. M. New compounds: derivatives of some imido compounds likely to possess therapuetic acitivy. J Pharm Sci. 1968 Dec;57(12):2176–2179. doi: 10.1002/jps.2600571236. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES